X-linked adrenoleukodystrophy and primary adrenal insufficiency

Area of Science:

• Genetics and Molecular Biology
• Endocrinology
• Neuroscience

Background:

• X-linked adrenoleukodystrophy (X-ALD) is a rare neurodegenerative disorder caused by ABCD1 gene mutations, leading to very long chain fatty acid (VLCFA) accumulation.
• VLCFA accumulation disrupts adrenal cortex function, causing primary adrenal insufficiency (PAI) in a significant proportion of X-ALD patients.
• The exact mechanisms linking X-ALD and PAI remain unclear, necessitating further investigation into shared pathophysiology.

Purpose of the Study:

• To elucidate the complex relationship between X-ALD and PAI.
• To explore the underlying pathophysiological mechanisms connecting VLCFA accumulation and adrenal dysfunction.
• To review current diagnostic approaches and therapeutic strategies for X-ALD-related PAI.

Main Methods:

• Literature review of studies on X-ALD, ABCD1 gene mutations, VLCFA metabolism, and PAI.
• Analysis of existing data on the prevalence and clinical presentation of PAI in X-ALD patients.
• Synthesis of current understanding regarding adrenal pathogenesis in X-ALD.

Main Results:

• X-ALD is characterized by defective peroxisomal β-oxidation of VLCFAs, leading to their accumulation in the adrenal cortex.
• PAI is a common feature of X-ALD, affecting up to 70% of patients, with variable presentation.
• VLCFA accumulation is implicated in adrenal cell membrane dysfunction and impaired ACTH receptor activity, contributing to PAI.

Conclusions:

• Early VLCFA assessment is crucial for male children with PAI to enable timely diagnosis of X-ALD.
• Individualized glucocorticoid replacement therapy is essential for managing X-ALD-related PAI.
• Further research is needed to fully understand the pathogenesis and optimize treatment for X-ALD-related PAI.